Michael Yeaman

Michael Yeaman

Company: University of California

Job title: Professor of Medicine; Chief Molecular Medicine; Director Institute for Infection & Immunity


Panel & Audience Discussion: Supercharging Antigen-Specific Approaches to Autoimmune Disease Patients: Evaluating the Next Steps to Move Forward as a Field 3:45 pm

Selecting antigens – what makes a ‘good’ antigen? Assessing preclinical models – what should we move towards for regulatory buy-in? Creating a biomarker toolbox – what biomarkers could be a tolerance endpoint? Honing clinical study design – what are key considerations for tolerance?Read more

day: Conference Day Two

Accelerating Immune Tolerance in Neurological Diseases: Neuromyelitis Optica Spectrum Disorder (NMOSD) as a Model of Progress 9:00 am

Proving and following the desired impact of tolerance on the immune system Moving towards harmonization of clinical trial design and implementation in NMOSD Specifying biomarkers of tolerigenesis in NMOSD and neurological diseases Updating outcome measures of efficacy, durability, and patient quality of lifeRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.